X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1950) 1950
Publication (140) 140
Newsletter (66) 66
Book Review (33) 33
Book Chapter (27) 27
Conference Proceeding (11) 11
Dissertation (5) 5
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1355) 1355
index medicus (1256) 1256
neuromyelitis optica (1118) 1118
clinical neurology (982) 982
female (914) 914
multiple sclerosis (838) 838
adult (743) 743
male (741) 741
magnetic resonance imaging (723) 723
neurosciences (687) 687
multiple-sclerosis (686) 686
neuromyelitis-optica (644) 644
middle aged (620) 620
neurology (471) 471
diagnostic-criteria (398) 398
aquaporins (389) 389
aquaporin 4 - immunology (344) 344
optic neuritis (340) 340
neuromyelitis optica - diagnosis (339) 339
diagnosis (318) 318
adolescent (308) 308
neuromyelitis optica - pathology (303) 303
young adult (303) 303
neuromyelitis optica - immunology (300) 300
research (284) 284
aquaporin-4 (270) 270
antibodies (261) 261
aged (257) 257
neuromyelitis (254) 254
spinal cord - pathology (242) 242
diagnosis, differential (239) 239
disease (226) 226
mri (221) 221
retrospective studies (219) 219
aquaporin 4 (210) 210
care and treatment (205) 205
autoantibodies - blood (204) 204
child (201) 201
spinal cord (200) 200
brain - pathology (195) 195
immunology (195) 195
myelitis (192) 192
patients (177) 177
autoimmunity (175) 175
multiple sclerosis - diagnosis (175) 175
nmo (172) 172
lesions (171) 171
neuromyelitis optica - complications (170) 170
brain (165) 165
demyelination (163) 163
neuromyelitis optica - blood (161) 161
autoantibodies (160) 160
medicine & public health (160) 160
transverse myelitis (158) 158
neuromyelitis optica - diagnostic imaging (154) 154
multiple sclerosis - pathology (152) 152
immunoglobulin g (151) 151
neuromyelitis optica - drug therapy (148) 148
nuclear magnetic resonance--nmr (147) 147
neuromyelitis optica spectrum disorder (144) 144
acute disseminated encephalomyelitis (142) 142
marker (139) 139
neuritis (137) 137
central nervous system (132) 132
ophthalmology (130) 130
analysis (126) 126
immunoglobulins (125) 125
nmo-igg (125) 125
recurrence (124) 124
pathogenesis (122) 122
medical research (121) 121
neuroimaging (121) 121
animals (118) 118
magnetic resonance imaging - methods (118) 118
autoantibodies - immunology (116) 116
prognosis (116) 116
neuromyelitis optica spectrum disorders (115) 115
risk factors (112) 112
health aspects (110) 110
nervous system (109) 109
neuromyelitis optica - physiopathology (109) 109
spectrum (109) 109
viral antibodies (108) 108
autoimmune diseases (107) 107
children (106) 106
neuroradiology (104) 104
anti-aquaporin-4 antibody (103) 103
follow-up studies (103) 103
criteria (101) 101
cerebrospinal fluid (100) 100
medicine, experimental (100) 100
disease progression (99) 99
disorders (99) 99
immunoglobulin g - blood (97) 97
psychiatry (97) 97
cerebrospinal-fluid (96) 96
multiple sclerosis - immunology (96) 96
usage (96) 96
inflammation (94) 94
medicine (94) 94
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1940) 1940
French (26) 26
German (22) 22
Spanish (11) 11
Japanese (10) 10
Chinese (4) 4
Czech (4) 4
Hungarian (3) 3
Korean (3) 3
Danish (1) 1
Dutch (1) 1
Polish (1) 1
Romanian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 280
Background: A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has been shown to be seropositive for myelin oligodendrocyte glycoprotein... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Therapy | Multiple sclerosis | Natalizumab | Optic neuritis | Vaccination | Electrophysiology | Infections | Longitudinally extensive transverse myelitis | Cerebrospinal fluid | Ofatumumab | Transverse myelitis | McDonald criteria | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Evoked potentials | Methotrexate | Glatiramer acetate | Autoantibodies | Rituximab | Oligoclonal bands | Pregnancy | Treatment | Magnetic resonance imaging | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Outcome | Interferon beta | Wingerchuk criteria 2006 and 2015 | IPND criteria | Neuromyelitis optica spectrum disorders (NMOSD) | Azathioprine | Barkhof criteria | Methotrexate Azathioprine | MEDUSA-HEAD ATAXIA | ANTIDIURETIC-HORMONE SECRETION | IMMUNOLOGY | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | EXTENSIVE TRANSVERSE MYELITIS | PURKINJE-CELL ANTIBODIES | SPINAL-CORD BIOPSY | POSITIVE NEUROMYELITIS-OPTICA | PREGNANCY-RELATED RELAPSE | NEUROSCIENCES | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Myelin-Oligodendrocyte Glycoprotein - genetics | Brain - diagnostic imaging | Age Distribution | Neuromyelitis Optica - therapy | Humans | Middle Aged | Cardiolipins - immunology | Male | Young Adult | Vaccination - methods | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Child | Optic Nerve - diagnostic imaging | Aquaporin 4 - immunology | Treatment Outcome | Neuromyelitis Optica - diagnostic imaging | Autoantibodies - cerebrospinal fluid | Adolescent | Sex Factors | Aged | Neuromyelitis Optica - epidemiology | Cohort Studies | Vision Disorders - etiology | Measurement | Care and treatment | Physiological aspects | Development and progression | Neuromyelitis optica | Diagnosis | Research
Journal Article
Neurology, ISSN 0028-3878, 07/2017, Volume 89, Issue 3, pp. 269 - 278
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 02/2018, Volume 89, Issue 2, pp. 127 - 137
ObjectiveWe characterised the clinical course, treatment and outcomes in 59 patients with relapsing myelin oligodendrocyte glycoprotein (MOG)... 
acute disseminated encephalomyelitis | myelin oligodendrocyte glycoprotein antibodies | outcomes | therapy | optic neuritis | SURGERY | MULTICENTER | PSYCHIATRY | MULTIPHASIC DISSEMINATED ENCEPHALOMYELITIS | CNS | CLINICAL NEUROLOGY | CHILDREN | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | NEUROMYELITIS-OPTICA | RITUXIMAB | DISEASE | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Brain - diagnostic imaging | Demyelinating Autoimmune Diseases, CNS - diagnostic imaging | Neuromyelitis Optica - therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Infant | Male | Neuromyelitis Optica - immunology | Demyelinating Autoimmune Diseases, CNS - immunology | Demyelinating Autoimmune Diseases, CNS - physiopathology | Young Adult | Rituximab - therapeutic use | Immunotherapy | Myelitis, Transverse - physiopathology | Adult | Female | Child | Optic Neuritis - immunology | Myelitis, Transverse - immunology | Myelitis, Transverse - therapy | Demyelinating Autoimmune Diseases, CNS - therapy | Encephalomyelitis, Acute Disseminated - therapy | Optic Neuritis - therapy | Optic Neuritis - diagnostic imaging | Neuromyelitis Optica - physiopathology | Encephalomyelitis, Acute Disseminated - physiopathology | Myelitis, Transverse - diagnostic imaging | Neuromyelitis Optica - diagnostic imaging | Encephalomyelitis, Acute Disseminated - diagnostic imaging | Magnetic Resonance Imaging | Autoantibodies - immunology | Mycophenolic Acid - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Optic Neuritis - physiopathology | Encephalomyelitis, Acute Disseminated - immunology | Adolescent | Aged | Prednisone - therapeutic use | Cohort Studies | Immunologic Factors - therapeutic use | Care and treatment | Usage | Demyelinating diseases | Health aspects | Myelin proteins | Neurology | Multiple sclerosis | Immunoglobulins | Disease | Laboratories | Aquaporins | Software | Glycoproteins | Adults | Patients | Psychiatry | 1506 | Neuro-Inflammation
Journal Article
Neurology, ISSN 0028-3878, 08/2017, Volume 89, Issue 9, pp. 900 - 908
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 08/2016, Volume 87, Issue 8, pp. 897 - 905
Journal Article
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 11/2016, Volume 13, Issue 1, p. 281
Background: Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) are present in a subset of aquaporin-4 (AQP4)-IgG-negative patients with optic neuritis... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Myelitis | Myelin oligodendrocyte glycoprotein (MOG) antibodies | Respiratory insufficiency | Optic neuritis | Cerebellitis | Intractable nausea and vomiting | MOG-IgG | Rhombencephalitis | Facial nerve palsy | Hearing loss | Diplopia Internuclear ophthalmoplegia (INO) | Ataxia | Neuromyelitis optica spectrum disorders (NMOSD) | Brainstem encephalitis | Longitudinally extensive transverse myelitis (LETM) | IMMUNOLOGY | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | ACUTE DISSEMINATED ENCEPHALOMYELITIS | EXTENSIVE TRANSVERSE MYELITIS | AQUAPORIN-4 ANTIBODY | INTERFERON-BETA | CLINICAL-COURSE | NEUROSCIENCES | LESIONS | OPTICA SPECTRUM DISORDERS | NEUROMYELITIS-OPTICA | DIAGNOSTIC-CRITERIA | Myelin-Oligodendrocyte Glycoprotein - immunology | Neuromyelitis Optica - drug therapy | Age Factors | Immunoglobulin G - blood | Encephalitis - diagnostic imaging | Humans | Middle Aged | Male | Neuromyelitis Optica - immunology | Interferon-beta - therapeutic use | Young Adult | Rituximab - therapeutic use | Myelitis - immunology | Adult | Female | Disability Evaluation | Brain Stem - diagnostic imaging | Myelitis - blood | Myelitis - pathology | Encephalitis - immunology | Neuromyelitis Optica - blood | Neuromyelitis Optica - diagnostic imaging | Blood-Brain Barrier - pathology | Magnetic Resonance Imaging | Adolescent | Brain Stem - physiopathology | Encephalitis - blood | Cohort Studies | Prevention | Immunoglobulin G | Immunotherapy | Influence | Brain damage | Research | Health aspects | Myelin proteins | Risk factors
Journal Article